不同透析间期与血液透析患者心肺适能的关系
本研究在28例血液透析患者中,于2天和3天透析间期末行心肺运动试验,比较心肺适能差异。结果显示3天间期末VO2peak等指标较2天间期末更低,该效应主要由额外间期日液体蓄积驱动。
要点
- 3天透析间期末较2天间期末VO2peak更低
- 该差异主要由额外间期日液体蓄积驱动
- 透析患者心肺适能低于年龄性别匹配对照
核心结论
- 3天透析间期与运动峰值VO2进一步受损相关,该效应主要由额外间期日液体蓄积驱动。
研究设计与样本
- 28例血液透析患者随机接受2天和3天间期末心肺运动试验及肺功能检查,另评估14例年龄性别匹配对照。
- 采用配对或独立t检验及相关非参数检验比较参数变化,并用双变量相关和广义线性混合模型分析关联。
主要发现
- 2天间期末VO2peak(ml/kg per minute)为15.2±4.2,3天间期末为13.6±2.8,差异有统计学意义(P < 0.001)。
- 2天间期末VO2peak(ml/min)为1188±257,3天间期末为1074±224(P < 0.001)。
- 2天间期末VO2peak(% predicted)为58.9±9.2,3天间期末为52.3±8.6(P < 0.001)。
- 2天间期末最大工作负荷为90.1±23.2,3天间期末为79.3±25.1(P < 0.001);运动时长、峰值心率及氧脉搏在3天间期末亦更低。
- 广义线性混合模型纳入透析间期体重增长为随机协变量后,VO2peak(ml/kg per minute)差异减弱;生物阻抗谱过度水合指数变化与VO2peak变化中度相关。
关键数值与推荐
- 血液透析患者2天和3天间期末所有主要CPET参数均低于对照。
- VO2无氧阈(ml/kg per minute及ml/min)在2天与3天间期末差异无统计学意义。
- 1秒用力呼气容积在两次评估间相似。
临床怎么用
- 对血液透析患者评估心肺适能时需考虑透析间期长度的影响。
- 管理3天间期液体蓄积可能有助于减轻心肺适能受损。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: This is the first study exploring differences in cardiorespiratory fitness assessed with cardiopulmonary exercise testing between the 2-day and the 3-day interdialytic interval. The 3-day interdialytic interval was associated with further impaired cardiorespiratory fitness. This effect was predominantly driven by excess fluid accumulation during the extra interdialytic day. BACKGROUND: Long interdialytic interval in thrice-weekly hemodialysis is associated with excess cardiovascular and all-cause mortality risk. Impaired cardiorespiratory fitness is a strong predictor of mortality in hemodialysis. This study investigated differences in cardiorespiratory fitness assessed with cardiopulmonary exercise testing (CPET) between the end of the 2-day and the 3-day interdialytic interval. METHODS: A total of 28 hemodialysis patients, randomized in two different sequences of evaluation, underwent CPET and spirometry examination at the end of the 2-day and the 3-day intervals. The primary outcome was the difference in oxygen uptake at peak exercise (VO2peak [ml/kg per minute]) assessed with CPET. Volume status was assessed with interdialytic weight gain, lung ultrasound, bioimpedance spectroscopy, and inferior vena cava measurements. A total of 14 age-matched and sex-matched controls were also evaluated. Comparisons of changes in parameters of interest were performed with paired or independent t-tests or relevant nonparametric tests, as appropriate. Bivariate correlation analyses and generalized linear mixed models were used to examine associations between changes in CPET parameters and volume indices. RESULTS: Hemodialysis patients at the end of both 2-day and 3-day intervals presented lower values in all major CPET parameters than controls. VO2peak (ml/kg per minute) was significantly higher at the end of the 2-day than the 3-day interval (15.2±4.2 versus 13.6±2.8; P < 0.001); the results were similar for VO2peak (ml/min) (1188±257 versus 1074±224; P < 0.001) and VO2peak (% predicted) (58.9±9.2 versus 52.3±8.6; P < 0.001). Numerical but no statistically significant differences were detected in VO2 anaerobic threshold (ml/kg per minute) and VO2 anaerobic threshold (ml/min) between the two time points. Maximal work load (90.1±23.2 versus 79.3±25.1; P < 0.001), exercise duration, heart rate at peak exercise, and oxygen pulse also showed lower values at the end of the 3-day interval. Forced expiratory volume in 1-second levels were similar between the two evaluations. Generalized linear mixed model analysis, including interdialytic weight gain as random covariate, attenuated the observed differences in VO2peak (ml/kg per minute). Changes in bioimpedance spectroscopy–derived overhydration indexes were moderately correlated with changes of VO2peak (ml/kg per minute). CONCLUSIONS: The 3-day interval was associated with further impairment of VO2 at peak exercise. This effect was predominantly driven by excess fluid accumulation during the extra interdialytic day.
引用
- Pella E, Boulmpou A, Boutou A, et al. Different Interdialytic Intervals and Cardiorespiratory Fitness in Patients Undergoing Hemodialysis. Clin J Am Soc Nephrol. 2024. PMID: 38407848. doi:10.2215/CJN.0000000000000435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。